BRAIN Biotech AG
XETRA:BNN

Watchlist Manager
BRAIN Biotech AG Logo
BRAIN Biotech AG
XETRA:BNN
Watchlist
Price: 2.45 EUR 3.81% Market Closed
Market Cap: €53.5m

Wall Street
Price Targets

BNN Price Targets Summary
BRAIN Biotech AG

Wall Street analysts forecast BNN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BNN is 6.12 EUR with a low forecast of 4.55 EUR and a high forecast of 8.4 EUR.

Lowest
Price Target
4.55 EUR
86% Upside
Average
Price Target
6.12 EUR
150% Upside
Highest
Price Target
8.4 EUR
243% Upside
BRAIN Biotech AG Competitors:
Price Targets

Revenue
Forecast

17% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
17% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 11 years the compound annual growth rate for BRAIN Biotech AG's revenue is 17%. The projected CAGR for the next 4 years is 8%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BNN's stock price target?
Price Target
6.12 EUR

According to Wall Street analysts, the average 1-year price target for BNN is 6.12 EUR with a low forecast of 4.55 EUR and a high forecast of 8.4 EUR.

What is BRAIN Biotech AG's Revenue forecast?
Projected CAGR
8%

For the last 11 years the compound annual growth rate for BRAIN Biotech AG's revenue is 17%. The projected CAGR for the next 4 years is 8%.

Back to Top